KEY INSIGHTSLorecivivint (SM04690) is a small-molecule inhibitor targeting the Wnt pathway, delivered through intra-articular injection, and is being explored as a potential disease-modifying osteoarthritis drug (DMOAD). Preclinical studies with vehicle-c…
KEY INSIGHTSLNA043 is an innovative ANGPTL3 (angiopoietin-like 3) agonist designed to specifically target and repair damaged cartilage while influencing multiple pathways involved in cartilage regeneration. This drug is being explored as a potential groun…
KEY INSIGHTSJTA-004 is an innovative treatment in development for managing knee osteoarthritis pain through intra-articular injections. This advanced osteoarthritis (OA) medicine features a proprietary blend of hyaluronic acid and plasma protein, substanc…
KEY INSIGHTSINVOSSA is a groundbreaking cell and gene therapy designed to treat knee osteoarthritis with a single intra-articular injection. Clinical trials conducted in the United States and globally have demonstrated that INVOSSA can significantly relie…
KEY INSIGHTSELIXCYTE is an allogeneic stem cell product derived from adipose tissue, designed to regulate the immune system, reduce inflammation, and promote chondrocyte proliferation while supporting the normal function of damaged chondrocytes. This ther…
KEY INSIGHTSCNTX-4975 is currently being evaluated as a treatment for moderate to severe knee osteoarthritis (OA) pain. It is a highly purified, synthetic form of trans-capsaicin administered via injection directly to the pain site. This innovative treatm…
KEY INSIGHTSAMZ001 is a new topical gel formulation of diclofenac, developed specifically to treat knee osteoarthritis (OA) pain. With a high-strength concentration of 3.06% diclofenac sodium, AMZ001 stands out in the osteoarthritis medication landscape d…
Pharmacy Market: Industry Trends and Global Forecasts, till 2035: Distribution by Type of Pharmacy (Retail Pharmacy, e-pharmacy, Hospital Pharmacy, Other Pharmacies), Type of Product Offered (Drugs / Pharmaceuticals, Medical Devices and Other Pharmacy Products), Availability (Prescription Products and Over-the-counter Products), Type of Drug (Branded / Patented Drugs and Generic Drugs), Type of Drug Molecule (Small Molecules and Biologics), Type of e-pharmacy Platforms (App-based Platforms and Web-based Platforms), Therapeutic Area (Oncological Disorders, Cardiovascular Disorders, Neurological Disorders, Infectious Diseases, Metabolic Disorders, Respiratory Disorders, Dermatological Disorders, Genetic Disorders, Autoimmune / Inflammatory Disorders and Other Disorders), Key Players and Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa and Latin America)
The Pharmacy Market is expected to reach USD 2.4 trillion by 2024 anticipated to grow at a CAGR of 5% during the forecast period 2024-2035.A recent study investigates the pharmacy industry, analyzing trends, market dynamics, competitive landscape, company…
Report Details
The HIV Drugs & Injectables Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful f…
Global Homeopathy Market: Analysis By Source (Plant, Minerals and Animal), By Type (Dilutions, Tablets, Tinctures, Boichemics, Ointments, and Others), By Application (Immunology, Analgesic and Antipyretic, Gastroenterology, Respiratory, Dermatology, Neurology, and Others), By End Use (Homeopathic Clinics, Retail Pharmacies, E-Retailers, and Others), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
Homeopathy is a medical system founded on the principle of "like cures like," where substances that cause symptoms in a healthy individual are used in highly diluted forms to treat similar symptoms in a sick person. Developed in the late 18th century by S…
KEY FINDINGSThe global RNA interference (RNAi) drug delivery market size was $66,442.85 million in 2023 and is expected to reach $406,320.39 million by 2032, growing at a CAGR of 22.24% during the forecast period. The base year considered for the study is…
KEY FINDINGSThe United Kingdom RNA interference (RNAi) drug delivery market is expected to develop at a CAGR of 23.08% over the forecast period of 2024-2032. It is set to reach a revenue of $20807.84 million by 2032. MARKET INSIGHTSThe United Kingdom RNA …
KEY FINDINGSThe South Korea RNA interference (RNAi) drug delivery market is predicted to develop at a CAGR of 21.61% over the forecast period of 2024-2032. It is set to reach a revenue of $6901.97 million by 2032. MARKET INSIGHTSThe South Korea RNA interf…
KEY FINDINGSThe Germany RNA interference (RNAi) drug delivery market is approximated to grow at a CAGR of 22.94% over the forecast period of 2024-2032. It is set to reach a revenue of $23164.24 million by 2032. MARKET INSIGHTSThe Germany RNA interference …
KEY FINDINGSThe global antibody drug conjugates contract manufacturing market is estimated to progress at a CAGR of 12.47% during the forecast period 2024-2032. Numerous aspects stimulate the market growth: the rising demand for targeted therapies, the gr…
KEY FINDINGSThe United States antibody drug conjugates contract manufacturing market is approximated to develop at a CAGR of 12.29% during the forecast period 2024-2032. Different enablers elevate market growth, the rising demand for targeted therapies, t…
KEY FINDINGSThe France antibody drug conjugates contract manufacturing market is predicted to develop at a CAGR of 11.82% during the forecast period 2024-2032. Various enablers promote market growth, the rising demand for targeted therapies, the growing i…
KEY FINDINGSThe China antibody drug conjugates contract manufacturing market is expected to progress at a CAGR of 12.34% during the forecast period 2024-2032. Diverse enablers foster market growth, the rising demand for targeted therapies, the growing inc…
mRNA Synthesis and Manufacturing Market (3rd Edition): Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Product (Drug Substances (APIs) and Drug Products (FDFs)), Application Area (mRNA-based Vaccines and mRNA-based Therapeutics), Therapeutic Area (Infectious Diseases, Oncological Disorders and Other Disorders) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World)
mRNA Synthesis and Manufacturing Market (3rd Edition): Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Product (Drug Substances (APIs) and Drug Products (FDFs)), Application Area (mRNA-based Vaccines and mRNA-based Therapeutics),…
Global Anti-Epileptic Drugs Market: Analysis By Drug Generation (First Generation Second Generation, and Third Generation), By Distribution Channel (Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Online Providers), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028
The global Anti-Epileptic Drugs (AEDs) market in 2022 stood at US$9.39 billion and is likely to reach US$11.47 billion by 2028. Anti-Epileptic Drugs (AEDs) represent a non-invasive imaging technology that produces comprehensive images of internal body str…